At Parthenon, Patient Centricity is a Driving Force.
We collaborate with patient foundations to bring medicines with curative potential to patients faster.
Patient Advocacy lead
Amanda Linkous, PhD
Dr. Amanda Linkous previously served as the Director of the Starr Foundation Cerebral Organoid Translational Core at Weill Cornell Medicine (New York, NY). She has extensive expertise in Precision Medicine-based screening platforms including patient-derived 3D organoid models of recalcitrant cancers such as glioblastoma, small cell lung cancer, and metastatic melanoma. Amanda’s patient-centric efforts have facilitated partnerships with numerous academic institutions, pharmaceutical companies, and non-profit organizations.
“My focus has always been the patient. Cancer is complicated, but helping patients and their families shouldn’t be.
At Parthenon, we decode the complexity of cancer to enhance treatment options and improve patient outcomes.”